Health ❯Healthcare

Drug Efficacy

Cancer Epidemiology Weight Management Pharmacology Public Companies Pharmaceutical Stocks Stock Market Patient Care Chronic Illness Management Clinical Research

FDA Approves Regeneron and Sanofi’s Dupixent for Bullous Pemphigoid

The FDA cited ADEPT Phase 2/3 trial data showing sustained remission alongside reduced corticosteroid exposure in elderly patients.

Statins Linked to 61% Reduced Cancer Mortality in CLL and SLL Patients

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock